TOPS System
Premia Spine, Ltd. · Decision date Sep 9, 2026
What did the FDA decide?
Premia Spine, Ltd. holds PMA P220002/S011 for the TOPS™ System, a posterior spinal element prosthesis (product code QWK, orthopedic specialty). The record describes this supplement as a 30-Day Notice for a process change involving a manufacturer, sterilizer, packager or supplier. The stated change is the addition of a subcontractor, Triangle Manufacturing Co., Inc., to manufacture pedicle screw components used with the TOPS™ implant.
FDA recorded the decision as OK30 on 2026-09-09. That action applies to the supplement and the subcontractor change it covers, not to a new approval of the full TOPS™ System. The source does not describe the pedicle screw specifications, the manufacturing processes affected, or any conditions attached to the decision, and no supporting documents are listed, so those details remain unknown.
Whether the added subcontractor affects component supply, traceability or post-market obligations cannot be determined from this record alone and would require the underlying FDA documents.
FDA approval order statement
addition of an additional subcontractor for the manufacturing of pedicle screw components to be used with the TOPS implant - Triangle Manufacturing Co., Inc.
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Sep 9, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P220002/S011
- Regulatory pathway
- PMA supplement
- Applicant
- Premia Spine, Ltd.
- Product code
- QWK
- Decision code
- OK30
- Decision date
- Sep 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, posterior spinal elements.
- Applicant
- Premia Spine, Ltd.
- Product code
- QWK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220002. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220002 · Original PMA
TOPS System
P220002/S011 received
Application receipt date recorded by FDA.
P220002/S011 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P220002. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220002
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TOPS SystemP220002 | Premia Spine, Ltd. | PMA approval | Jun 15, 2023 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Premia Spine, Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 7 Giborey Israel St., Ramat Poleg, Netanya, 4250407
Sources and methodology
- Original FDA record: P220002/S011
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records